FDA warns Sandoz on unvalidated manufacturing
The FDA says that Sandoz, the generics arm of Swiss drug major Novartis, failed to validate manufacturing processes used to produce metoprolol succinate ER tablets at its plant in Wilson, North Carolina.
Archives for August 26, 2008
Equateq bullish about lipid API market
A facility operated by fatty acid specialist Equateq on the island of Lewis in Scotland has met with UK good manufacturing practice (GMP) standards for the production of lipid-based APIs for the drug industry.
Pharma manufacturing: people on the move
in-PharmaTechnologist.com presents its latest round-up of personnel changes in the pharmaceutical sector.